FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                       
1. Name and Address of Reporting Person * Ugwumba Chidozie 2. Issuer Name and Ticker or Trading Symbol BiomX Inc. [ PHGE ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
_____ Officer (give title below)    __X__ Other (specify below)
Exit Form 4 - former 10% owner
(Last)          (First)          (Middle)
609 SW 8TH STREET, SUITE 365		 3. Date of Earliest Transaction (MM/DD/YYYY)
8/10/2022
(Street)
BENTONVILLE, AR 72712
(City)        (State)        (Zip)
 4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
 6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  8/10/2022    S    17769  D $0.74  3620077 (1) I  By SymBiosis, LLC 
Common Stock  8/11/2022    S    9824  D $0.744  3610253 (1) I  By Symbiosis, LLC 
Common Stock  8/12/2022    S    11406  D $0.734  3598847 (1) I  By Symbiosis, LLC 
Common Stock  8/15/2022    S    7200  D $0.747  3591647 (1) I  By SymBiosis, LLC 
Common Stock  8/16/2022    S    8563  D $0.729  3583084 (1) I  By SymBiosis, LLC 
Common Stock  8/17/2022    S    21335  D $0.688  3561749 (1) I  By SymBiosis, LLC 
Common Stock  8/18/2022    S    7764  D $0.683  3553985 (1) I  By SymBiosis, LLC 
Common Stock  8/19/2022    S    14600  D $0.639  3539385 (1) I  By SymBiosis, LLC 
Common Stock  8/22/2022    S    5000  D $0.657  3534385 (1) I  By SymBiosis, LLC 
Common Stock  8/23/2022    S    5900  D $0.638  3528485 (1) I  By SymBiosis, LLC 
Common Stock  8/24/2022    S    8665  D $0.652  3519820 (1) I  By SymBiosis, LLC 
Common Stock  8/25/2022    S    26945  D $0.718  3492875  I  By SymBiosis, LLC 
Common Stock  8/26/2022    S    60628  D $0.616  3432247 (1) I  By SymBiosis, LLC 
Common Stock  8/29/2022    S    11533  D $0.571  3420714 (1) I  By SymBiosis, LLC 
Common Stock  8/30/2022    S    13487  D $0.566  3407227 (1) I  By SymBiosis, LLC 
Common Stock  8/31/2022    S    4540  D $0.549  3402687 (1) I  By SymBiosis, LLC 
Common Stock  9/1/2022    S    8297  D $0.546  3394390 (1) I  By SymBiosis, LLC 
Common Stock  9/2/2022    S    2001  D $0.546  3392389 (1) I  By SymBiosis, LLC 
Common Stock  9/6/2022    S    6403  D $0.545  3385986 (1) I  By SymBiosis, LLC 
Common Stock  9/7/2022    S    8846  D $0.528  3377140 (1) I  By SymBiosis, LLC 
Common Stock  9/8/2022    S    4592  D $0.522  3372548 (1) I  By SymBiosis, LLC 
Common Stock  9/9/2022    S    13219  D $0.518  3359329 (1) I  By SymBiosis, LLC 
Common Stock  9/12/2022    S    1700  D $0.541  3357629 (1) I  By SymBiosis, LLC 
Common Stock  9/13/2022    S    2201  D $0.525  3335428 (1) I  By SymBiosis, LLC 
Common Stock  9/14/2022    S    2301  D $0.523  3353127 (1) I  By SymBiosis, LLC 
Common Stock  9/15/2022    S    3900  D $0.531  3349227 (1) I  By SymBiosis, LLC 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  The shares are directly held by SymBiosis, LLC.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Ugwumba Chidozie
609 SW 8TH STREET
SUITE 365
BENTONVILLE, AR 72712


Exit Form 4 - former 10% owner

Signatures
/s/ Chidozie Ugwumba 11/14/2022
**Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
BiomX (AMEX:PHGE)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more BiomX Charts.
BiomX (AMEX:PHGE)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more BiomX Charts.